Edition:
United States

Ypsomed Holding AG (YPSN.S)

YPSN.S on Swiss Exchange

159.20CHF
15 Dec 2017
Change (% chg)

CHF-0.10 (-0.06%)
Prev Close
CHF159.30
Open
CHF159.30
Day's High
CHF159.30
Day's Low
CHF158.20
Volume
11,357
Avg. Vol
21,976
52-wk High
CHF228.70
52-wk Low
CHF132.50

Latest Key Developments (Source: Significant Developments)

Ypsomed increases its forecast to an operating result of CHF 60 mln
Thursday, 9 Nov 2017 02:42am EST 

Nov 9(Reuters) - YPSOMED HOLDING AG ::SAYS FIRST SIX MONTHS OF 2017/18, A CONSOLIDATED TOTAL TURNOVER OF CHF 213.4 MILLION. THE GROWTH CORRESPONDS TO AN INCREASE IN TURNOVER OF 15.1 PCT (PREVIOUS YEAR: CHF 185.4 MILLION).SAYS THE NET PROFIT FOR THE REPORTING PERIOD AMOUNTS TO CHF 23.4 MILLION (PREVIOUS YEAR CHF 22.4 MILLION).SAYS OPERATING RESULT AMOUNTS TO CHF 26.9 MILLION WITH AN EBIT MARGIN OF 12.9  PCT.SAYS EXPECTS A GROWTH IN TURNOVER OF APPROXIMATELY 18 PCT VERSUS THE PRESENTLY FORECAST 15 PCT AND INCREASES THE FORECAST TO AN OPERATING RESULT OF AROUND CHF 60 MILLION FOR THE BUSINESS YEAR 2017/18.  Full Article

Ypsomed and US Bigfoot Biomedical company announce partnership
Tuesday, 24 Oct 2017 01:07am EDT 

Oct 24 (Reuters) - YPSOMED HOLDING AG ::‍YPSOMED AND US BIGFOOT BIOMEDICAL COMPANY TODAY ANNOUNCED THEIR AGREEMENT FOR A PARTNERSHIP​.‍YPSOMED WILL SUPPLY BIGFOOT BIOMEDICAL WITH A MODIFIED, PATENTED VERSION OF ORBIT INFUSION SET​.  Full Article

Ypsomed to separate from Insulet
Friday, 21 Jul 2017 01:12am EDT 

July 21 (Reuters) - YPSOMED HOLDING AG ::TO SEPARATE FROM INSULET AND EXTEND ITS PORTFOLIO WITH AN OWN PATCH PUMP IN MID-TERM.AFTER 30 JUNE 2018, INSULET CORP. WILL TAKE OVER OMNIPOD BUSINESS WORLDWIDE.DETAILS OF TRANSFER PROCESS ARE PRESENTLY BEING WORKED OUT BETWEEN TWO PARTIES.‍DISTRIBUTION AGREEMENT WITH INSULET CORP. WILL END AS PER 30 JUNE 2018​.‍PARTIES COULD NOT AGREE ON EXTENDING CONTRACT AS PRICE DEMANDED BY INSULET CORP. WOULD HAVE MADE CONTINUED ECONOMIC VIABILITY IMPOSSIBLE​.IN FUTURE, YPSOMED WILL FOCUS ON ITS OWN DEVELOPMENTS.IS TO RECEIVE SOME USD 50 MILLION IN COMPENSATION FROM INSULET CORP. TO SET UP EUROPEAN DISTRIBUTION STRUCTURES FOR MYLIFE OMNIPOD.  Full Article

Ypsomed Holding FY net profit up 29 pct at CHF 35.8 million
Wednesday, 24 May 2017 01:15am EDT 

May 24 (Reuters) - YPSOMED HOLDING AG ::FY SALES OF CHF 389.6 MILLION (PREVIOUS YEAR: CHF 336.9 MILLION).FY EBIT ALSO INCREASED BY 24.4% COMPARED TO PREVIOUS YEAR, FROM CHF 44.4 MILLION TO CHF 55.3 MILLION.FY NET PROFITS WERE RAISED BY 29.1% FROM CHF 35.8 MILLION TO CHF 46.2 MILLION.SOME DEMANDING TASKS LIE AHEAD FOR COMING FINANCIAL YEAR, BUT YPSOMED REMAINS CONFIDENT AND AGAIN EXPECTS A GROWTH IN SALES OF APPROXIMATELY 15% FOR FINANCIAL YEAR 2017/18.  Full Article

Ypsomed Holding FY net profit up at 35.8 mln Swiss francs
Friday, 20 May 2016 01:00am EDT 

Ypsomed Holding AG : FY consolidated sales totaling 336.9 million Swiss francs ($339.82 million) (prior year: 306.6 million Swiss francs) . FY EBIT also increased by 55.7 pct compared to the previous year, from 28.5 million Swiss francs to 44.4 million Swiss francs . For the current business year 2016/17, Ypsomed expects an accelerated growth in sales of around 12 pct and an EBIT of approx. 55 million Swiss francs . Shareholders shall be paid a dividend of 1.00 Swiss francs per registered share .FY net profit for the business year 2015/16 amounts to a total of 35.8 million Swiss francs, compared to the previous year at 19.4 million Swiss francs.  Full Article

BRIEF-Ypsomed increases its forecast to an operating result of CHF 60 mln

* SAYS FIRST SIX MONTHS OF 2017/18, A CONSOLIDATED TOTAL TURNOVER OF CHF 213.4 MILLION. THE GROWTH CORRESPONDS TO AN INCREASE IN TURNOVER OF 15.1 PCT (PREVIOUS YEAR: CHF 185.4 MILLION)